Authors
Latest:
Pediatric ocular surface reconstruction: Managing lesion excision challengesThis population requires careful attention from diagnosis through the entire postoperative process.
Latest:
Surgical innovation in dry eye disease: Salivary gland transplantA novel use of minor salivary glands offers lasting relief and visual improvement.
Latest:
Beyond mentoring: The power of sponsorship and advocacy in ophthalmologyTo create lasting change, ophthalmology must embrace the impact of sponsorship and advocacy—empowering the next generation of leaders with not just knowledge, but the opportunities to excel.
Latest:
Increasing your practice’s reach, relevance, and revenue with clinical trialsWorking as an investigator can prove to be a positive experience for physicians
Latest:
Q&A: The ELEVATUM Study with J. Fernando ArevaloThe ELEVATUM study explored faricimab's effectiveness in treating diabetic macular edema among underrepresented minorities, showcasing significant visual acuity improvements.
Latest:
Treating traumatic brain injury neuro-optometricallyPhysicians note the impact of prism lenses can be life-changing for patients.
Latest:
Ravi Patel, MD, shares ASCRS 2025 insights on enVista ASPIRE IOL user experienceDiscover how real-world evidence shapes cataract surgery practices, highlighting user satisfaction with enhanced monofocal IOLs at the 2025 ASCRS Annual Meeting.
Latest:
A Case of Neovascular AMD With Recurrent Subretinal FluidA retina specialist analyzes a case of neovascular age-related macular degeneration characterized by recurring subretinal fluid.
Latest:
Seeing the unseen: Improving early detection for patients with MacTelAdvanced imaging and awareness of systemic risk factors are essential.
Latest:
Glaucoma-focused session with Angelo P. Tanna, MD, launches Northwestern University’s “Dinner with the Experts” seriesDr. Tanna will kick off the new monthly subspecialty education series with a virtual session on September 9, 2025, focused on using OCT imaging and perimetry to track glaucoma progression.
Latest:
Tackling negotiations for contractsOn the 'Negotiations' episode of RWO: The Podcast, Dr. Lisa Nijm joins Drs. Nicole Bajic and Grayson Armstrong to discuss personal experiences with contract negotiation.
Latest:
Tear film imager may shift paradigm in the treatment of dry eye diseaseTFI employs spectral interference technology to image and map the corneal surface.
Latest:
Bridging disciplines and elevating care: A Q&A with John Gelles, OD, and Steven Greenstein, MDIn this Q&A, John D. Gelles, OD, and Steven Greenstein, MD, chat about what inspired them to launch the symposium, what makes this year’s agenda especially exciting, and why the future of refractive care depends on stronger collaboration between ODs and MDs.
Latest:
ASCRS 2025: Pinpointing your "why" and brushing up on clinical skills are vital to humanitarian ophthalmologyShehzad Batliwala, DO, known to his patients as Dr. Shehz, appeared on the ASCRS Foundation Symposium, where he discussed performing refractive surgery in low-resource, high-risk areas.
Latest:
Envision Summit 2025: Beyond the status quo in gene therapyAt the Envision Summit 2025 in San Juan, Puerto Rico, Mike Farkas, MD, discussed gene therapy research for retinal degenerations that sidetracks the current "status quo" therapies of AAV-based replacement and CRISPR-Cas9 genome editing.
Latest:
ARVO 2025: Retina extracellular vesicles in diabetic retinopathyAt ARVO 2025, in Salt Lake City, Utah, Emma Lessieur-Contreras, MD, PhD, talked about her poster on retina extracellular vesicles, and the role that they play on diabetic retinopathy.
Latest:
Q&A: Malvina Eydelman, MD, on leading CCOI and catalyzing global ophthalmic innovationShifting from a regulatory role to driving innovation directly, Eydelman discusses how the Collaborative Community on Ophthalmic Innovation is reshaping the field, streamlining outdated processes, and advancing patient-centered solutions worldwide.
Latest:
Presbyopia treatment success begins with patient-centered carePersonalizing treatment options and setting realistic expectations are crucial.
Latest:
Envision Summit 2025: New developments in glaucoma treatment and tailoring them to the patientAt the Envision Summit 2025 in San Juan, Puerto Rico, Rachel Simpson, MD, talked about new developments in glaucoma treatment and really how to tailor glaucoma treatment to the patient.
Latest:
Pass-through provides vehicle to drive innovationAs more novel ophthalmic drugs and devices become available under the CMS “pass-through”designation, practices should be proactive in embracing these products.
Latest:
The Residency Report: Study provides new insights into USH2A target end pointsResearchers evaluate key measures for tracking disease progression in Usher syndrome type 2–related retinal degeneration
Latest:
Children’s mental health and the impact of vision impairmentTwo studies conducted in collaboration with Orbis International explore how providing free glasses to children improves their ability to learn in school and that addressing visual impairment in children can alleviate depression and anxiety.
Latest:
Payment models for imaging: Procedures not covered by insurance policiesTips to help eye care providers navigate the maze of insurance issues.
Latest:
Posterior corneal elevation: Is there a role for premium IOLs?Trifocal IOLs can, if implanted with caution, be suitable for patients with keratoconus.
Latest:
Case 3: Treating nAMD in the Presence of Geographic AtrophyRetina experts deliberate on the role of fluorescein angiography in AMD and discuss initiation of anticomplement therapy for geographic atrophy in conjunction with anti-VEGF therapy for neovascular AMD.
Latest:
Cryopreserved amniotic membrane an option treatment of mechanical dry eyeReservoir restoration can re establish the normal anatomy and function of the conjunctiva.
Latest:
Study examines efficiency of physiotherapy in treating, preventing uncomplicated acquired myopiaResearch explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.
